Who Wins the Battle Against Obesity? A Network Meta‐Analysis Comparing Tirzepatide and Semaglutide

In this NMA, tirzepatide appeared to be superior to semaglutide in both body weight reduction and improvement of glycemic indices.

Authors

Institutions

Publication Details

Journal
Journal of Diabetes
Published
2026-02-01
DOI
https://doi.org/10.1111/1753-0407.70192
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Who Wins the Battle Against Obesity? A Network Meta‐Analysis Comparing Tirzepatide and Semaglutide

Ramon Huntermann, Jacinthe Khater, Michele Molinari, Júlia Cremonini Bernardi et al.
Journal of Diabetes
Diabetes Treatment and Management
article

Who Wins the Battle Against Obesity? A Network Meta‐Analysis Comparing Tirzepatide and Semaglutide

Ramon Huntermann, Jacinthe Khater, Michele Molinari, Júlia Cremonini Bernardi, Luana Zanon, V A Gomez, Deivyd V. S. Cavalcante, Caroline O. Fischer‐Bacca
article en

Abstract

In this NMA, tirzepatide appeared to be superior to semaglutide in both body weight reduction and improvement of glycemic indices.

Journal of DiabetesVol. 18(2)
University of North Texas (US), Lebanese University (LB), University of North Texas Health Science Center (US), Iberoamerican University (CR), Universidade para o Desenvolvimento do Alto Vale do Itajaí (BR)
Openalex Percentile: Top 62%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.